BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9150287)

  • 1. Antinociceptive effects of dynorphin peptides in a model of inflammatory pain.
    Beyer A; Schäfer M; Stein C
    Pain; 1997 Apr; 70(2-3):141-7. PubMed ID: 9150287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraplantar morphine on paw edema and pain-related behaviour in a rat model of repeated acute inflammation.
    Perrot S; Guilbaud G; Kayser V
    Pain; 1999 Nov; 83(2):249-57. PubMed ID: 10534597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive profiles of opioid peptide agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    Peptides; 1985; 6 Suppl 2():171-5. PubMed ID: 2867529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue.
    Schäfer M; Zhou L; Stein C
    Neuroscience; 1998 Jan; 82(2):603-11. PubMed ID: 9466464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin.
    Stein C; Gramsch C; Herz A
    J Neurosci; 1990 Apr; 10(4):1292-8. PubMed ID: 2158530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
    Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation.
    Perrot S; Guilbaud G; Kayser V
    Anesthesiology; 2001 May; 94(5):870-5. PubMed ID: 11388540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
    Zhou L; Zhang Q; Stein C; Schäfer M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
    Hua S; Cabot PJ
    Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
    Gogas KR; Presley RW; Levine JD; Basbaum AI
    Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of thermal edema in rat by des-Tyr-Dynorphin A.
    Thomas HA; Wei ET
    Peptides; 1995; 16(3):547-50. PubMed ID: 7651911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue.
    Hassan AH; Ableitner A; Stein C; Herz A
    Neuroscience; 1993 Jul; 55(1):185-95. PubMed ID: 7688879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1-8) in rats.
    Kitamura K; Akahori K; Yano H; Iwao K; Oka T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):273-8. PubMed ID: 10731039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
    Iwaszkiewicz KS; Hua S
    Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla.
    Fang FG; Haws CM; Drasner K; Williamson A; Fields HL
    Brain Res; 1989 Oct; 501(1):116-28. PubMed ID: 2572306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation.
    Maldonado R; Valverde O; Turcaud S; Fournié-Zaluski MC; Roques BP
    Pain; 1994 Jul; 58(1):77-83. PubMed ID: 7970841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia.
    Auh QS; Chun YH; Melemedjian OK; Zhang Y; Ro JY
    Brain Res Bull; 2016 Jul; 125():211-7. PubMed ID: 27450703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.